Get startedLog in
    Picture of PCI Biotech Holding ASA logo

    PCIBo — PCI Biotech Holding ASA News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: PCI Biotech Gets Orphan Drug Designation In South Korea

    Picture of PCI Biotech Holding ASA logoPCI Biotech Holding ASA
    28/05/2021 13:53
    May 28 (Reuters) - PCI Biotech Holding ASA  PCIB.OL :
    * REG-PCI BIOTECH RECEIVES ORPHAN DRUG DESIGNATION IN SOUTH
KOREA
FOR FIMAPORFIN IN THE TREATMENT OF BILE DUCT CANCER
    * MINISTRY OF FOOD AND DRUG SAFETY (MFDS) IN SOUTH KOREA HAS
GRANTED ORPHAN DRUG DESIGNATION TO CO'S LEAD PRODUCT CANDIDATE,
FIMAPORFIN

Source text for Eikon:  ID:nGNE12s1Pf 
Further company coverage:  PCIB.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on PCI Biotech Holding ASA

    See all news